Logo Logo

Publications by Poulin, Y.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Wollenberg, A.; Blauvelt, A.; Guttman-Yassky, E.; Worm, M.; Lynde, C.; Lacour, J.-P.; Spelman, L.; Katoh, N.; Saeki, H.; Poulin, Y.; Lesiak, A.; Kircik, L.; Cho, S. H.; Herranz, P.; Cork, M. J.; Peris, K.; Steffensen, L. A.; Bang, B.; Kuznetsova, A.; Jensen, T. N.; osterdal, M. L.; Simpson, E. L. (2020): Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). In: British Journal of Dermatology, Vol. 184, No. 3: pp. 437-449

Simpson, E. L.; Bieber, T.; Guttman-Yassky, E.; Beck, L. A.; Blauvelt, A.; Cork, M. J.; Silverberg, J. I.; Deleuran, M.; Kataoka, Y.; Lacour, J.-P.; Kingo, K.; Worm, M.; Poulin, Y.; Wollenberg, A.; Soo, Y.; Graham, N. M. H.; Pirozzi, G.; Akinlade, B.; Staudinger, H.; Mastey, V.; Eckert, L.; Gadkari, A.; Ardeleanu, M. (2017): Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2). In: Journal Der Deutschen Dermatologischen Gesellschaft, Vol. 15: p. 79

Simpson, E. L.; Bieber, T.; Guttman-Yassky, E.; Beck, L. A.; Blauvelt, A.; Cork, M. J.; Silverberg, J. I.; Deleuran, M.; Kataoka, Y.; Lacour, J.-P.; Kingo, K.; Worm, M.; Poulin, Y.; Wollenberg, A.; Soo, Y.; Graham, N. M. H.; Pirozzi, G.; Akinlade, B.; Staudinger, H.; Mastey, V.; Eckert, L.; Gadkari, A.; Stahl, N.; Yancopoulos, G. D.; Ardeleanu, M. (2016): Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. In: New England Journal of Medicine, Vol. 375, No. 24: pp. 2335-2348

This list was generated on Wed Aug 17 13:22:36 2022 CEST.